Persistence of Multidrug-Resistant Acinetobacter baumannii Isolates Harboring blaOXA-23 and bap for 5 Years |
Sung, Ji Youn
(Department of Biomedical Laboratory Science, Far East University)
Koo, Sun Hoe (Department of Laboratory Medicine, College of Medicine, Chungnam National University) Kim, Semi (Department of Laboratory Medicine, College of Medicine, Chungnam National University) Kwon, Gye Cheol (Department of Laboratory Medicine, College of Medicine, Chungnam National University) |
1 | Sung JY, Kwon KC, Cho HH, Koo SH. 2011. Antimicrobial resistance determinants in imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii complex isolated in Daejeon, Korea. Korean J. Lab. Med. 31: 265-270. DOI |
2 | Poirel L, Pitout JD, Nordmann P. 2007. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2: 501-512. DOI |
3 | Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70: 119-123. DOI |
4 | Pour NK, Dusane DH, Dhakephalkar PK, Zamin FR, Zinjarde SS, Chopade BA. 2011. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol. Med. Microbiol. 62: 328-338. DOI |
5 | Vidal R, Dominguez M, Urrutia H, Bello H, Garcia A, Gonzalez G, Zemelman R. 1997. Effect of imipenem and sulbactam on sessile cells of Acinetobacter baumannii growing in biofilm. Microbios 91: 79-87. |
6 | Van Looveren M, Goossens H, Arpac Steering Group. 2004. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect. 10: 684-704. DOI |
7 | Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27: 351-353. DOI |
8 | Coelho J, Woodford N, Afzal-Shah M, Livermore D. 2006. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob. Agents Chemother. 50: 756-758. DOI |
9 | Bou G, Cerveró G, Domínguez MA, Quereda C, Martínez-Beltrán J. 2000. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 6: 635-643. DOI |
10 | Brossard KA, Campagnari AA. 2012. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect. Immun. 80: 228-233. DOI |
11 | Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. M100-S21. CLSI, Wayne, Pensylvania. |
12 | Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15: 167-193. DOI |
13 | Ellington MJ, Kistler J, Livermore DM, Woodford N. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59: 321-322. DOI |
14 | Girlich D, Poirel L, Nordmann P. 2010. First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate. Antimicrob. Agents Chemother. 54: 578-579. DOI |
15 | Goh HM, Beatson SA, Totsika M, Moriel DG, Phan MD, Szubert J, et al. 2013. Molecular analysis of the Acinetobacter baumannii biofilm-associated protein. Appl. Environ. Microbiol. 79: 6535-6543. DOI |
16 | Jean SS, Hsueh PR. 2011. High burden of antimicrobial resistance in Asia. Int. J. Antimicrob. Agents 37: 291-295. DOI |
17 | Koo SH, Kwon KC, Cho HH, Sung JY. 2010. Genetic basis of multidrug-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea. Korean J. Lab. Med. 30: 498-506. DOI |
18 | Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. 2009. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology155: 2333-2341. DOI |
19 | Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2: 95-108. DOI |
20 | Hall-Stoodley L, Stoodley P. 2005. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 13: 7-10. DOI |
21 | Loehfelm TW, Luke NR, Campagnari AA. 2008. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J. Bacteriol. 190: 1036-1044. DOI |
22 | Luo TL, Rickard AH, Srinivasan U, Kaye KS, Foxman B. 2015. Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system. Front. Microbiol. 12: 182. |
23 | Martí S, Rodríguez-Baño J, Catel-Ferreira M, Jouenne T, Vila J, Seifert H, et al. 2011. Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res. Notes 11: 4-5. |
24 | O’Toole GA, Kolter R. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28: 449-461. DOI |